Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial
Por um escritor misterioso
Descrição
PDF) Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis
PDF) Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis
Efficacy and Safety of Upadacitinib in Patients with Ankylosing Spondylitis with Intolerance to And/or Lack of Efficacy of Prior Biologic Therapy: A Subgroup Analysis - ACR Meeting Abstracts
Secukinumab (Novartis) IL-17A inhibitor safe
Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis - ScienceDirect
POS1104 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES THROUGH WEEK 52 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2
Correlation Among Disease Activity, Musculoskeletal Function, and Quality of Life in Patients with Ankylosing Spondylitis with Mild to Moderate Radiographic Signs
Consistently Good Clinical Response in Patients with Early Axial Spondyloarthritis After 3 Years of Continuous Treatment with Etanercept: Longterm Data of the ESTHER Trial
Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study, BMC Musculoskeletal Disorders
Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome
